Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$314,004
+$125,141 QoQ
Shares Held
51,308
+87.7% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Derivatives in VNDA
reported options exposure · as of Jun 30, 2020CallValue
$0
CallShares
45,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. VNDA ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in VNDA
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $314,004 | 51,308 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $188,863 | 27,332 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $606,312 | 68,743 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $244,479 | 48,994 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $186,774 | 39,571 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $174,484 | 38,014 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $160,507 | 33,509 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $122,737 | 26,170 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $144,344 | 25,548 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $84,118 | 20,467 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $74,692 | 17,700 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $62,767 | 14,530 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $410,416 | 62,279 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $351,829 | 51,816 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,667 | 1,985 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $44,892 | 4,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,531 | 5,003 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $971,618 | 85,908 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,583,167 | 100,903 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,329,390 | 310,933 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 904,290 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $8,952,459 | 416,200 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 566,241 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $2,201,449 | 146,568 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 ALXN | — | 873,464 | Shares | Defined | 2021-02-09 | |
| 2020-12-31 | $1,849,006 | 140,716 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 ALXN | — | 924,664 | Shares | Defined | 2020-11-05 | |
| 2020-09-30 | $1,286,595 | 133,188 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 ALXN | — | 999,778 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 ALXN | — | 45,700 | Call | Defined | 2020-08-13 | |
| 2020-06-30 | $1,627,337 | 142,250 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 45,700 | Call | Defined | 2020-05-14 | |
| 2020-03-31 ALXN | — | 45,800 | Put | Defined | 2020-05-14 | |
| 2020-03-31 ALXN | — | 1,338,969 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $2,035,624 | 196,489 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||